<DOC>
	<DOC>NCT01932775</DOC>
	<brief_summary>Objective: To investigate the performance (safety) of the GlucoTab system for glycaemic management in non-critically ill patients with type 2 diabetes at general wards.</brief_summary>
	<brief_title>Efficacy, Usability Study of the GlucoTab System for Glycaemic Management in Type 2 Diabetic Patients at General Wards</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Informed consent obtained after being advised of the nature of the study Male or female aged â‰¥18 years Type 2 diabetes (treated with diet, oral agents, noninsulin injected antidiabetic medicine, insulin therapy or any combination of the four) or newly diagnosed hyperglycaemia which requires s.c. insulin therapy Type 1 diabetes, gestational diabetes Any disease or condition which the investigator or treating physician feels would interfere with the trial or the safety of the patient Pregnancy Any mental condition rendering the patient incapable of giving his consent Known or suspected allergy to insulin glargine or insulin aspart Continuous parenteral nutrition Participation in another trial which can influence the software algorithm</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>